Search results for: Biontech

On April 18, 2023 the FDA announced [1] it amended the emergency use authorizations (EUAs) so that "monovalent Moderna and Pfizer-BioNTech COVID-19 vaccines are no longer authorized for use in the United States", only the bivalent (original and omicron BA.4/BA.5 strains) vaccines will be authorised, so as "to simplify the vaccination schedule for most individuals". [2] The bivalent products were never authorized for primary dose, especially not to new borns and babies, they were only considered as boosters, and on the back of 8 mice. Without any clinical trials for safety or efficacy, the FDA has approved the bivalent vaccine for unvaccinated adults, whom were never part of the bivalent "trials" - they've already adopted the "flu vaccine" model. [3]

On January 26, 2023 the FDA's advisory committee, VRBPAC, held their 178th meeting to Discuss Future Vaccination Regimens Addressing COVID-19.   Discussions included next generation vaccines such as mucosal, plus Moderna, Pfizer/BioNTech and Novavax got to speak about their Vaccine Platforms, updating the genetic code. With the FDA accepting these vaccine platforms all they need to do in the future is "assess" the "varient" for whatever virus they choose to target with the vaccine! The emergency use of COVID-19 vaccines during the pandemic has allowed, in record time, Big Pharma companies to establish their new technology vaccine platforms into the market, Platforms that can encode for whatever virus variant they choose! What are the chances of 3 independent companies, introducing brand new technology products, all successfully gaining regulatory approval at the same time, in a record timeframe?  Now every emerging and existing disease can have a vaccine solution - just as Gates [1, 2], Fauci [2], Daszak et al wanted. [4, 5]

On August 9, 2021 the Pentagon announced it's intention to mandate all active duty US military personnel to recieve a COVID-19 vaccine by September 15, 2021. [1, 2] Defense Secretary Lloyd Austin wrote “I will seek the president’s approval to make the vaccines mandatory no later than mid-September, or immediately upon [full approval of the vaccine by the Food and Drug Administration], whichever comes first". The FDA granted full approval to the Pfizer-BioNTech COVID vaccine on August 23, 2021!

On Jannuary 6, 2021, Moderna's COVID-19 mRNA vaccine received Conditional Marketing Approval (CMA) by the European Medicines Agency (EMA), meeting their criteria,  stating after clinical trial evidence showed efficacy (94·1%) and safety. This is the second CMA, following Pfizer. [1, 2, 3]

On December 3, 2020, just one day after the UK became the first country to grant emergency use authorisation for Pfizer-BioNTech's COVID-19 vaccine, it was reported that Pfizer's CEO Albert Bourla said in an interview with NBC that the company is "not certain" if their vaccine will prevent transmission, "I think this is something that needs to be examined" he said. [1, 2]

On October 12, 2022 the FDA announced they awarded emergency use authorizations (EUAs) for both Moderna and Pfizer-BioNTech bivalent mRNA (original strain plus omicron variant BA.4 and BA.5) COVID-19 Vaccines for use as a booster dose in children 5-11 years old - when the bivalent vaccine was NOT tested on children - only 8 mice! The FDA/CDC always promote that their "approved" vaccines "goes through extensive safety testing"! - not when it comes to kid or EUA!

On January 22, 2023 it was reported that China National Biotec Group (CNBG), a subsidiary of China National Pharmaceutical Group Co Ltd (Sinopharm) had received regulatory approval by their State Drug Administration to begin clinical trials of China's first mRNA COVID-19 vaccine targeting specifically the Omicron variants. [1] Jia Weiguo, chief scientist at CNBG's Virogin Biotech Company, based in Shanghai, says the new advanced mRNA-LNP encapsulation technology "has proved effective in preventing infection in animal trials"! Virogin, "has built a research and development platform, as well as production lines with an annual capacity of 2 billion doses of mRNA vaccine. They can quickly produce mRNA vaccines to deal with pandemics".  "China's annual COVID-19 vaccine production capacity has reached 7 billion doses" Gao Fu, former head of China's CDC [and sat on Event 201 panel, etc] "suggested that approval procedures for COVID-19 vaccines should be similar to those for influenza vaccines". The only foreign mRNA vaccines allowed in China are BioNTech doses shipped by Germany late last year and being given to expatriate Germans living there, but Moderna are in talks with China. Currently global emergency approved vaccines are for Wuhan strain (original) or a bivalent (Wuhan plus and Omicron variant)..> READ MORE